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The Shared Decision for Osteoarthritis 
Treatments
Basem Al-Omari*, Angela Bate and Peter McMeekinFaculty of Health and Life Science, Northumbria University, UK
Abstract In recent years, there has been increasing interest in collaborative, shared decision-making between phy-sicians and patients. The shared decision-making process involves healthcare professionals and patients working together to make a healthcare decision. For patients and clinicians to reach mutual decisions about treatment, they must have an understanding of the condition, treatment options available, and the 
risks and benefits of each treatment. This is a very complex process when dealing with osteoarthritis (OA) patients. Treatment recommendations for OA vary depending on several factors, which results in patients having to continuously trade-off these factors against each other. Another challenge is that these factors differ between individuals and healthcare settings. Therefore, healthcare professionals must understand pa-tients’ preferences to achieve a shared decision and be able to reach a mutual agreement regarding OA 
treatment. This is a complicated process that requires time, effort, and expertise.
Introduction
Osteoarthritis patients’ treatment preferences
Generally, pharmacological treatment guidelines are based on extensive clinical data, e.g. Randomised Controlled Trials (RCTs). Although research evidence such as RCTs regarding the effectiveness of treatment is one of the fundamental components of evidence-based practice, 
alone it is insufficient for making decisions about patient care [1]. Healthcare practitioners are encouraged to implement evidence-based practice in conjunction with patient-centred 
care [2]. Recently, there has been increased attention toward combining patient centred care 
and evidence-based practice despite tension and conflict between the two [3]. Since then, many researchers and academics focused on the inclusion of patients’ preferences and values in the decision-making process. 
In the UK, the NICE OA guidelines [4] suggest that treatment and care of OA should take into account patients’ treatment preferences and beliefs, especially when there is uncertainty about the probability of treatment outcomes, or when there are two or more treatment 
options that offer a similar balance between benefits and risks [5]. Taking into account patients’ preferences is advocated as an optimal model of collaborative care between patients 
and clinicians [5]. Patients’ preference is also considered to influence patients’ compliance, 
which is one of the vital components of the successful management of OA pain [6]. Patients’ values and preferences contribute to patients’ concordance of any prescribed treatment. Simply, if the patients did not like the treatment, they are not going to adhere to it. Therefore, 
patients’ values and preferences, should be considered alongside clinicians’ expertise and 
best available evidence. Prioritising treatments most important to the patient requires 
considering the individual patient’s preferences and trade-offs as well as the expression of 
their particular pattern of illness and the significance of particular symptoms [7], therefore, 
Clinicians face substantial challenges in dealing well with chronic illnesses [8].In OA, treatment recommendations vary depending on symptom severity and patients’ 
prior experience with other treatments. It is also suggested that if health care practitioners 
know more about patients’ preferences, care could be cheaper and more effective [6]. In a cross-sectional study assessing the relation between patients’ beliefs and reported 
adherence [9], it was found that over a third of the patients had strong concerns about their 
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medication based on beliefs about the dangers of dependence or long-term effects. These results suggest that patients’ beliefs about the need for medication are weighed against concerns about the potential adverse effects. Thus, patients’ medication preferences 
may influence their compliance with treatment. As a predictor of patients’ compliance, patient beliefs about the medication were found to be more powerful than clinical and sociodemographic 
factors. Indeed, this accounted for 19% of the explained variance 
in compliance [9]. For patients to make informed decisions about their care, they 
need to understand their treatment options [10]. When patients are making these decisions about their preferred treatment choice, they are considering different characteristics of this treatment such 
as the method of administration, effectiveness, side effects, etc [11]. Furthermore, patient preferences about medication type for chronic 
knee pain is affected by many factors, e.g. previous experience of medication, other illness, pain elsewhere, convenience and severity 
of pain [12]. The pharmacological treatment recommended for 
mild OA symptoms (paracetamol) has modest efficacy but no inherent risks of adverse effects, while potentially more effective options, such as NSAIDs or opioids, present a higher risk of side 
effects [5,13]. Therefore, patients with OA are continually faced 
with decisions that imply relevant trade-offs between benefits and 
risks [5]. However, we do not currently have a clear picture of the 
relative importance of the different factors influencing OA patients’ medication preferences or if these factors differ individually or 
according to the healthcare settings [7]. Identifying the relative importance of these factors may allow physicians to prescribe 
medications that match patients’ preferences. For example, it would be easier for the physicians to prescribe medication to a patient who has mild OA if the physicians were aware that the patient had a preference for avoiding side effects over the method of administration and frequency of use.
A study conducted by Landmark and colleagues [14] exploring how physicians elicit patient preferences in shared decision-making and found that physicians occasionally present a treatment option to the patients based on hypothetical patients’ preferences that are made by physicians themselves which constrains the patient’s 
freedom of choice and exerts a pressure to accept the physician’s recommendation. In other occasions, physicians assume that older patients with limited health knowledge may not want to participate 
in the treatment decision making process [15]. These assumptions are inconsistent with both the evidence and contemporary models 
of care [16]. Patients’ preferences are vital when considering multi 
attributes treatment options for patients [17]. Matching patients’ preferences to treatments has been shown to be effective in 
symptom reduction [18]. Thus, treatment decisions are dependent 
on patient preferences [14]. However, it must be acknowledged that eliciting patients’ preferences is a complicated process that 
requires time, effort, and expertise.The United Kingdom (UK) government’s vision of the National Health Services (NHS) in England is for patients and clinicians to reach mutual decisions about treatment, with a shared understanding of the condition, the options available, and the risks 
and benefits of each of those [19] which resulted in the government producing a proposal for “no decision about me, without me” policy. This document included proposals to give the patients and public more say over their care and treatment with more opportunity to make informed choices, as a means of securing better care and 
better outcomes [20]. The main emphasis of the policy was to create a culture where the shared decision making is the standard procedure during the clinician-patient consultation. 
Shared decisions and eliciting patients’ preferences re-
garding osteoarthritis treatmentsThe process that involves health professionals and patients working together to make healthcare decision is called “shared 
decision making” [21]. Shared decision making is particularly recommended for preference-sensitive medical decisions, where two or more equivalent treatment options are available or 
consequences of the treatment affect the patients’ daily life [18]. Therefore, a shared decision-making approach is suitable in the 
treatment of chronic conditions [22] such as OA. Shared decision-making can be considered as “a bilateral process that leads to a joint and equivalent treatment decision 
based on shared information between clinician and patient” [23]. This highlights the importance of both the information provided to patients and the information received from them regarding 
their preferences. Carnes [24] found that shared decisions, where doctors take account of patient preferences, encourage compliance with the treatment process and positive perception of the drug used. To facilitate this process of shared decision making between clinicians and their OA patients, clinicians must understand patients’ preferences for OA treatment, which requires the understanding of factors such as patients’ perceptions and beliefs 
associated with the different treatment options [25]. Clinicians could use the information of the trade-off that OA patients make, to 
tailor treatment to match the patients’ preferences [26]. 
The King’s Fund [19] suggests that the principle of shared 
decision-making in the context of a clinical consultation should: a) support patients to articulate their understanding of their condition and of what they hope treatment (or self-management support) will achieveb) inform patients about their condition, about the treatment 
or support options available, and about the benefits and risks of eachc) ensure that patients and clinicians arrive at a decision based on mutual understanding of this informationd) record and implement the decision reached.These points were some of the main principles of the “no decision about me, without me” policy. However, in order for this process to be successful, clinicians must understand patients’ preferences, beliefs, and knowledge about the treatment.The process of eliciting patients’ preferences can be complicated 
and time-consuming. Thus, the expectation that patients become 
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more involved in making treatment decisions poses a challenge for 
doctors [27]. This challenge could be due to several reasons such as; that patients vary in how much they would like to be involved in the treatment decision-making process, their treatment preferences 
may change over time [28], and treatment options may include 
several factors to be considered [29]. Therefore, methods of eliciting patients’ preferences are essential tools for practitioners to involve 
their patients in the shared-decision making process. Frewer [25] suggest that to take full account of what patients consider as best treatment, there is a need to develop an innovative method that is sensitive to the differences in patient preferences. Therefore, work is needed with patients to gain their perspectives to understand how a method of eliciting preference for use in routine primary 
care might be structured [8]. This suggests that patients must not only be involved in the consultation itself, but they must also be consulted and involved in the development of a practical method to 
elite their preferences [17]. There are many methods of studying patients’ preferences 
concerning OA treatment [30]. Qualitative methods have been used to study patients’ decisions regarding OA medication and some, but a limited number of the previous work have used standard quantitative questionnaires to determine patients’ preferences 
[26].There is a suggestion that the trade-off that OA patients make of one treatment attribute against another has not been widely 
studied [31], which highlights the need for methods to understand this trade-off. The need for such methods encouraged behavioural scientists to develop alternative techniques to traditional survey for eliciting preference that involves studying choice behaviour 
rather than just asking about the different choices [32]. Bridges 
and colleagues [33] suggested that the flexibility of the patient preference elicitation method should capture the interest of most outcome researchers. Conjoint analysis is one method that can be used to study 
preferences [34], by quantifying the relative influence of different 
treatment factors on decision-making [35]. The most advanced conjoint analysis technique is Adaptive Choice Based Conjoint (ACBC) that used and comprehensively described and evaluated 
by Al-Omari and colleagues [7,17,29] to elicit patients preferences 
for OA treatment. ACBC is a computerised and/or web-based interactive conjoint analysis questionnaire that can analyse patients’ preferences and has the potential to identify individual preferences as a practical basis for concordant prescribing for OA 
in clinical practice [7,36]. 
ConclusionIdentifying patients’ preferences with respect to OA treatment may allow physicians to prescribe treatments that match patients’ preferences, enhance compliance with medications, and enhance patients’ satisfaction and coping with this chronic disease. In order to identify patients’ preferences regarding the pharmaceutical treatment of OA, there is a need to develop an innovative method that addresses the differences in patient preferences. The ACBC method potentially offers an approach to incorporate patients’ 
preferences into the shared decision-making process regarding OA treatment.
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